胸部主动脉覆膜支架市场:开发平台(管线)报告(开发阶段,市场区隔,地区·国家,法规途径,主要企业),2024最新版
市场调查报告书
商品编码
1617532

胸部主动脉覆膜支架市场:开发平台(管线)报告(开发阶段,市场区隔,地区·国家,法规途径,主要企业),2024最新版

Thoracic Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

出版日期: | 出版商: GlobalData | 英文 56 Pages | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

胸主动脉覆膜支架用于透过微创手术加强部分主动脉来治疗胸主动脉瘤。

本报告提供胸部主动脉覆膜支架pu市场相关调查,产品概要与正在开发的开发中产品趋势,各种各样的处于开发阶段的产品的比较分析和进行中的临床试验相关资讯,参与企业的最近趋势等资讯。

目录

第1章 目录

第2章 简介

  • 胸部主动脉覆膜支架概要

第3章 开发中的产品

  • 胸部主动脉覆膜支架 - 各开发阶段平台产品
  • 胸部主动脉覆膜支架 - 各地区开发中产品
  • 胸部主动脉覆膜支架 - 各法规途径开发中产品
  • 胸部主动脉覆膜支架 - 估计核准日开发中产品
  • 胸部主动脉覆膜支架 - 进行中的临床试验

第4章 胸部主动脉覆膜支架- 各公司正在开发的开发中产品

  • 胸部主动脉覆膜支架企业-各开发阶段的开发中产品
  • 胸部主动脉覆膜支架-各开发阶段的开发中产品

第5章 胸部主动脉覆膜支架企业与产品概要

第6章 胸部主动脉覆膜支架-最近的趋势

第7章 附录

  • 调查手法
  • 关于GlobalData
  • 咨询方式
  • 免责声明
Product Code: GDME1891EPD

GlobalData's Medical Devices sector report, "Thoracic Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Thoracic Aortic Stent Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Thoracic aortic stent grafts are used to treat thoracic aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Thoracic Aortic Stent Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Thoracic Aortic Stent Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Thoracic Aortic Stent Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Thoracic Aortic Stent Grafts Overview

3 Products under Development

  • 3.1 Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • 3.2 Thoracic Aortic Stent Grafts - Pipeline Products by Territory
  • 3.3 Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • 3.4 Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • 3.5 Thoracic Aortic Stent Grafts - Ongoing Clinical Trials

4 Thoracic Aortic Stent Grafts - Pipeline Products under Development by Companies

  • 4.1 Thoracic Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
  • 4.2 Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development

5 Thoracic Aortic Stent Grafts Companies and Product Overview

6 Thoracic Aortic Stent Grafts- Recent Developments

  • 6.1 Oct 31, 2024: LeMaitre Reports Q3 2024 Results
  • 6.2 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024
  • 6.3 Aug 30, 2024: MicroPort Scientific Reports Earnings Results for the Half Year Ended June 30, 2024
  • 6.4 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference
  • 6.5 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference
  • 6.6 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance
  • 6.7 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
  • 6.8 Jun 13, 2024: Medtronic Confirms Global Layoffs
  • 6.9 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

  • Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Thoracic Aortic Stent Grafts - Pipeline Products by Territory
  • Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • Thoracic Aortic Stent Grafts - Ongoing Clinical Trials
  • Thoracic Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
  • Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Glossary

List of Figures

  • Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Thoracic Aortic Stent Grafts - Pipeline Products by Territory
  • Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • Thoracic Aortic Stent Grafts - Ongoing Clinical Trials